Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partial Endocardial Cushion Defects.

Canadian Medical Association journal·2010
Same author

Commentaries.

Canadian Medical Association journal·2010
Same author

Commentaries.

Canadian Medical Association journal·2010
Same author

Type A behaviour pattern: relationship to coronary heart disease, personality and life adjustment.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1979
Same author

Exercise prescription for apparently healthy individuals and for cardiac patients.

Cardiovascular clinics·1978
Same author

Serum cholesterol and triglyceride measurements in Canadian physicians.

Canadian Medical Association journal·1975
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

The overweight physician.

J E Merriman

    Canadian Family Physician Medecin De Famille Canadien
    |May 15, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Overweight physicians exhibit higher risks for coronary heart disease, including reduced cardiorespiratory fitness and increased hypertension. This study highlights significant health concerns among male physicians regarding weight and cardiovascular health.

    More Related Videos

    An Acupoint Catgut-embedding Therapy for Treating Obesity
    04:50

    An Acupoint Catgut-embedding Therapy for Treating Obesity

    Published on: April 4, 2025

    Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
    05:18

    Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

    Published on: November 22, 2024

    Related Experiment Videos

    Last Updated: Jun 13, 2026

    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    An Acupoint Catgut-embedding Therapy for Treating Obesity
    04:50

    An Acupoint Catgut-embedding Therapy for Treating Obesity

    Published on: April 4, 2025

    Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
    05:18

    Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

    Published on: November 22, 2024

    Area of Science:

    • Cardiology
    • Preventive Medicine
    • Physician Health

    Background:

    • Coronary risk factors are prevalent in male physicians.
    • Physician wellness is crucial for public health.
    • Understanding risk factors in physicians can inform targeted interventions.

    Purpose of the Study:

    • To investigate coronary risk factors in a cohort of male physicians.
    • To compare health metrics between normal weight and overweight physicians.
    • To identify specific health disparities within the physician population.

    Main Methods:

    • A cohort of 456 male physicians (aged 24-84) was assessed.
    • Physicians were categorized by weight: normal, overweight, and obese.
    • Coronary risk factors, cardiorespiratory fitness (maximum oxygen uptake), hypertension, and electrocardiogram (ECG) abnormalities were evaluated.

    Main Results:

    • Overweight physicians demonstrated lower maximum oxygen uptake, indicating reduced cardiorespiratory fitness.
    • A higher incidence of hypertension was observed in overweight physicians.
    • Overweight physicians had more abnormalities in resting electrocardiograms compared to normal weight physicians.
    • Hypercholesterolemia incidence was higher in this physician cohort than in the general Canadian population.

    Conclusions:

    • Physician weight status is strongly associated with adverse cardiovascular risk factors.
    • Interventions targeting weight management in physicians may reduce hypertension and improve cardiovascular health.
    • Elevated hypercholesterolemia rates in physicians warrant further investigation and preventive strategies.